According to the American Lung Association, lung cancer is the leading cancer killer in both men and women in the U.S. At least 8.6 million Americans qualify as high risk for lung cancer and are recommended to receive annual screening with low-dose CT scans. Lung CT Screening for individuals at high risk has the potential to dramatically improve lung cancer survival rates by finding the disease at an earlier, more treatable stage. At Winship Cancer Institute of Emory University, a highly coordinated multidisciplinary team provides advanced care and clinical trials option with cutting edge new therapies for lung cancer patients.
We hosted a live chat with Seth D. Force, MD and Suresh Ramalingam, MD of Winship Cancer Institute of Emory University’s lung cancer team on Wednesday, January 11 where we answered your questions about lung cancer risk factors, lung CT screening, symptoms and therapy. We received a lot of great questions that our physicians were able to answer. Below are some highlights from live chat, and you can read the full chat transcript here.
Lung Cancer Live Chat Highlights
Question: Is a chest x-
Dr. Force and Dr. Ramalingam: Chest xrays have not been shown to be helpful for lung cancer screening as confirmed by several older clinical trials.
Question: At what point should a patient seek specialist if diagnosed with nodule
Dr. Force and Dr. Ramalingam:
Question: What are some of lung cancer symptoms that should worry us?
Dr. Force and Dr. Ramalingam: Good question!
Thank you to everyone who participated in our lung cancer live chat with Dr. Force and Dr. Ramalingam. Learn more here.